Biotech | May 19, 2026
NunaBio secures £6.5 million to scale DNA manufacturing platform
Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics
Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics
India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
40+ most innovative startups with disruptive contributions across MedTech, Medical Devices, BioPharma, Cell and Gene Therapy, AI and ML, Nutraceuticals, and Biomarkers exhibited their cutting-edge solutions
The Union Budget 2026–27 accords strong priority to the upgradation and expansion of healthcare infrastructure and medical education
A dedicated Life Sciences Innovation Fund, scalable up to Rs. 1,000 crore, will catalyze early- and growth-stage innovation, support deep-tech ventures – particularly biotherapeutics
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK
Use of Wipro Holmes Artificial Intelligence capabilities will lead to faster development of advanced therapeutics, improving patient outcomes
Subscribe To Our Newsletter & Stay Updated
